Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 204 followers
Latest posts
Last updated about 7 hours ago
STAT+: What was big at AACR? A drug, a diagnostic, and a dog. Oh and a vaccine, too.
about 7 hours ago
You’re reading the web edition of AACR in 30 Seconds, STAT’s guide...
STAT+: Supreme Court sides with HHS on formula used to pay hospitals for treating low-income patients
about 7 hours ago
The Supreme Court on Tuesday rejected hospitals’ argument that the federal government...
STAT+: Sales of BridgeBio’s new heart drug blow past expectations
about 8 hours ago
BridgeBio’s recently approved heart drug brought in $36.7 million in sales in...
STAT+: Gilead will pay $202 million to settle charges of paying kickbacks to docs for boosting HIV drug sales
about 8 hours ago
Gilead Sciences agreed to pay $202 million to settle allegations of paying...
STAT+: Despite Kennedy’s stated support, funding for Women’s Health Initiative remains in limbo
about 8 hours ago
The word came down at 9 a.m. Pacific on April 14 that...
STAT+: Congress returns to a jam-packed agenda — here’s what we’re watching
about 11 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
A closer look at the health tech executive leading Medicare
about 12 hours ago
You’re reading the web edition of STAT’s Health Tech newsletter, our guide...
This is the end of GLP-1 compounding as we know it
about 14 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Pharmalittle: We’re reading about FDA chaos delaying a rare disease drug, Merck’s U.S. investment, and more
about 15 hours ago
Top of the morning to you. And a fine one it is...
Over the last century, where people lived was linked to how long they lived
about 16 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly
about 16 hours ago
Novo Nordisk is expanding its efforts to sell its obesity drug Wegovy...
STAT+: Amid FDA chaos, approval of a rare disease drug gets delayed — again
about 18 hours ago
File this under “So close, yet so far.” After several years of...